Dora I. McCarthy

1.9k total citations
21 papers, 1.6k citations indexed

About

Dora I. McCarthy is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Dora I. McCarthy has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 4 papers in Small Animals. Recurrent topics in Dora I. McCarthy's work include Antifungal resistance and susceptibility (19 papers), Fungal Infections and Studies (13 papers) and Nail Diseases and Treatments (4 papers). Dora I. McCarthy is often cited by papers focused on Antifungal resistance and susceptibility (19 papers), Fungal Infections and Studies (13 papers) and Nail Diseases and Treatments (4 papers). Dora I. McCarthy collaborates with scholars based in United States, Iran and Japan. Dora I. McCarthy's co-authors include Annette W. Fothergill, Michael G. Rinaldi, John R. Graybill, Deanna A. Sutton, Nathan P. Wiederhold, Kerry O’Donnell, Mary E. Brandt, Ning Zhang, David M. Geiser and Thomas F. Patterson and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Dora I. McCarthy

21 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora I. McCarthy United States 18 1.1k 873 519 387 164 21 1.6k
Adrien Székely United Kingdom 24 1.4k 1.2× 1.1k 1.3× 363 0.7× 198 0.5× 134 0.8× 30 1.8k
Sevtap Arıkan Türkiye 19 989 0.9× 745 0.9× 275 0.5× 172 0.4× 173 1.1× 40 1.3k
Isabel Pujol Spain 22 712 0.6× 535 0.6× 470 0.9× 247 0.6× 213 1.3× 51 1.4k
Shallu Kathuria India 24 2.0k 1.8× 1.4k 1.6× 690 1.3× 399 1.0× 304 1.9× 35 2.4k
Ziauddin Khan Kuwait 30 1.9k 1.7× 1.8k 2.1× 548 1.1× 248 0.6× 191 1.2× 109 2.5k
Araceli Monzón Spain 19 1.3k 1.2× 1.1k 1.2× 467 0.9× 210 0.5× 307 1.9× 28 1.6k
María José Buitrago Spain 27 1.8k 1.6× 1.6k 1.8× 611 1.2× 349 0.9× 266 1.6× 66 2.3k
Michaela Lackner Austria 30 1.9k 1.7× 1.5k 1.8× 600 1.2× 366 0.9× 310 1.9× 104 2.5k
Marie Desnos‐Ollivier France 26 1.7k 1.5× 1.6k 1.8× 370 0.7× 322 0.8× 218 1.3× 60 2.2k
Teresa M. Dı́az-Guerra Spain 14 904 0.8× 630 0.7× 246 0.5× 241 0.6× 145 0.9× 20 1.1k

Countries citing papers authored by Dora I. McCarthy

Since Specialization
Citations

This map shows the geographic impact of Dora I. McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora I. McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora I. McCarthy more than expected).

Fields of papers citing papers by Dora I. McCarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora I. McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora I. McCarthy. The network helps show where Dora I. McCarthy may publish in the future.

Co-authorship network of co-authors of Dora I. McCarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Dora I. McCarthy. A scholar is included among the top collaborators of Dora I. McCarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora I. McCarthy. Dora I. McCarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Badali, Hamid, Connie Cañete‐Gibas, Dora I. McCarthy, et al.. (2022). Species Distribution and Antifungal Susceptibilities of Aspergillus Section Fumigati Isolates in Clinical Samples from the United States. Journal of Clinical Microbiology. 60(5). e0028022–e0028022. 28 indexed citations
2.
Badali, Hamid, Connie Cañete‐Gibas, Dora I. McCarthy, et al.. (2021). Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States. Journal of Clinical Microbiology. 59(9). e0123021–e0123021. 46 indexed citations
3.
Fothergill, Annette W., et al.. (2016). Effects of Treated versus Untreated Polystyrene on Caspofungin In Vitro Activity against Candida Species. Journal of Clinical Microbiology. 54(3). 734–738. 14 indexed citations
4.
Wiederhold, Nathan P., Laura K. Najvar, Annette W. Fothergill, et al.. (2015). The novel arylamidine T-2307 demonstratesin vitroandin vivoactivity against echinocandin-resistantCandida glabrata. Journal of Antimicrobial Chemotherapy. 71(3). 692–695. 37 indexed citations
5.
Wiederhold, Nathan P., Felipe Castro Gutiérrez, Jonathan R. Lindner, et al.. (2015). First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States. Journal of Clinical Microbiology. 54(1). 168–171. 134 indexed citations
6.
Fothergill, Annette W., Deanna A. Sutton, Dora I. McCarthy, & Nathan P. Wiederhold. (2014). Impact of New Antifungal Breakpoints on Antifungal Resistance in Candida Species. Journal of Clinical Microbiology. 52(3). 994–997. 80 indexed citations
7.
Wiederhold, Nathan P., Laura K. Najvar, Annette W. Fothergill, et al.. (2014). The Investigational Agent E1210 Is Effective in Treatment of Experimental Invasive Candidiasis Caused by Resistant Candida albicans. Antimicrobial Agents and Chemotherapy. 59(1). 690–692. 46 indexed citations
8.
Wiederhold, Nathan P., Laura K. Najvar, Annette W. Fothergill, et al.. (2014). The Novel Arylamidine T-2307 Maintains In Vitro and In Vivo Activity against Echinocandin-Resistant Candida albicans. Antimicrobial Agents and Chemotherapy. 59(2). 1341–1343. 30 indexed citations
9.
Wiederhold, Nathan P., Annette W. Fothergill, Dora I. McCarthy, & Amir Tavakkol. (2014). Luliconazole Demonstrates Potent In Vitro Activity against Dermatophytes Recovered from Patients with Onychomycosis. Antimicrobial Agents and Chemotherapy. 58(6). 3553–3555. 27 indexed citations
10.
Kirkpatrick, William R., Michael Bröker, Annette W. Fothergill, et al.. (2010). Screening for drug-resistantCandidayeasts with chromogenic agar. Medical Mycology. 48(6). 807–816. 3 indexed citations
11.
O’Donnell, Kerry, Deanna A. Sutton, Annette W. Fothergill, et al.. (2008). Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within theFusarium solaniSpecies Complex. Journal of Clinical Microbiology. 46(8). 2477–2490. 381 indexed citations
12.
Bocanegra, Rosie, et al.. (2005). Caspofungin and Liposomal Amphotericin B Therapy of Experimental Murine Scedosporiosis. Antimicrobial Agents and Chemotherapy. 49(12). 5139–5141. 18 indexed citations
14.
Fothergill, Annette W., et al.. (2002). In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes. Antimicrobial Agents and Chemotherapy. 46(5). 1581–1582. 269 indexed citations
15.
Iwen, Peter C., Lynne Sigler, Stefano Tarantolo, et al.. (2000). Pulmonary Infection Caused by Gymnascella hyalinospora in a Patient with Acute Myelogenous Leukemia. Journal of Clinical Microbiology. 38(1). 375–381. 23 indexed citations
16.
Jessup, Chad, Annette W. Fothergill, Dora I. McCarthy, et al.. (2000). A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.. PubMed. 12(1). 22–9. 23 indexed citations
17.
Kirkpatrick, William R., Sanjay G. Revankar, Robert K. McAtee, et al.. (1998). Detection of Candida dubliniensis in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates. Journal of Clinical Microbiology. 36(10). 3007–3012. 162 indexed citations
18.
Kirkpatrick, William R., Robert K. McAtee, Sanjay G. Revankar, et al.. (1998). Comparative Evaluation of National Committee for Clinical Laboratory Standards Broth Macrodilution and Agar Dilution Screening Methods for Testing Fluconazole Susceptibility of Cryptococcus neoformans. Journal of Clinical Microbiology. 36(5). 1330–1332. 24 indexed citations
19.
Kirkpatrick, William R., Thomas M. Turner, Annette W. Fothergill, et al.. (1998). Fluconazole Disk Diffusion Susceptibility Testing of Candida Species. Journal of Clinical Microbiology. 36(11). 3429–3432. 69 indexed citations
20.
Patterson, Thomas F., et al.. (1996). Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans. Journal of Clinical Microbiology. 34(12). 3237–3239. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026